Abstract
It should be stressed at the outset that this presentation will mainly point out the deficiencies in our knowledge rather than present any substantial body of scientifically significant data. There is a dearth of information on specific therapeutic efficacy of anti-anxiety agents in the geriatric population, In aspects of differential side effects, on potential differences in metabolic handling, and on drug interaction problems that may arise when anti-anxiety agents are given concurrently with drugs employed for medical management. In determining the therapeutic efficacy of these drugs we must consider such problems as a potentially high placebo response rate and the choice of psychological rating scales which are relevant and sensitive to an elderly population. Salzman and Shader have outlined the difficulties encountered by investigators in this area. We will discuss these problems in terms of each of the following categories: a) population, b) diagnosis, and c) chemotherapeutic agents.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aldrich, C.K., and Mendkoff, E. Relocation of the aged and disabled: A mortality study. J. Am. Ger. Soc., 11, 185–194, 1963.
Bender, A.D.: Pharmacologic aspects of aging: A survey of the effect of increasing age on drug activity in adults. J. Amer. Ger. Soc. 12; 114–134, 1964.
Blenkner, M. Environmental change and the aging individual. Gerontologist: 7, 101–105, 1967.
Chesrow; E.J., Kaplitz, S.E., Breme, J.T., Musci, J. and Sabatini, R. Use of a new benzodiazepine derivative (VALIUM) in chronically ill and disturbed elderly patients. J. Am. Ger. Soc. 10, 667–670, 1962.
Deutsch, M., Saxena, B.M., Lehmann, H.E. and Ban, T.A. Combined administration of thioridazine and fluoxymesterone in the treatment of geriatric patients. Curr. Ther. Res. 12, 805–509, 1970.
Feigenbaum, E.M. Assessment of behavioral changes and emotional disturbances in a custodial geriatric facility. Presented as a Scientific Exhibit, 124 Annual Meeting Amer. Psychiat. Assoc. Wash. D.C. May 3–7, 1971.
Gibson, I: I.J.M.: Barbiturate delirium. Practitioner 197: 345–7, 1966.
Jasnau, K.E. Individual versus mass transfer of neuropsychotic geriatric patients from mental hospitals to nursing homes, with special reference to the death rate. J. Am. Geriat. Soc. 15, 280–284, 1967.
Jones, T.H.: Chloriazepoxide and the geriatric patient. J. Am. Ger. Soc. 10, 259–263, 1962.
Kral, V.A. The use of thioridazine in aged people. Canad. Med. Ass. J. 84, 152, 1961.
Lawton, M.P. and Jaffee, S. Mrtality, morbidity, and voluntary change of residence of older people. Paper presented at Annual Meeting of American Psychological Association, Washington, Sept. 5, 1967.
Lieberman, M.A. Relationship of mortality rates to entrance to a home for the aged. Geriatrics, 16, 575–579, 1961.
Miller, D., and Lieberman, M.A. The relationship of affect state and adaptive capacity to reactions to stress. J. of Geront. 20, 492–297, 1965.
Roth, M. The natural history of mental disorder in old age. J. Ment. Sei. 101, 281, 1955.
Salzman, C., Gochansky, G.E., and Shader, R.I., Rating scales for geriatric psychopharmacology.
Salzman, C., Shader, R.I., and Perlman, M.: Psychopharmacology and the elderly, In Shader, R.I. and Di Mascio, A. (Eds.). Psychotropic Drug Side Effects. Williams and Wilkins, Baltimore, 1970, 261–279.
Shader, R.I. and DiMascio, A. Psychotropic Drug Side Effects. Williams and Wilkins, 1970.
Shahinian, S.F., Goldforb, A.I., and Turner, M. Death rate in relocated residents of nursing homes. Paper presented at 19th Annual Meeting of Gerontological Society. N.Y.: Nov. 4, 1966.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Plenum Press, New York
About this chapter
Cite this chapter
Gershon, S. (1973). Antianxiety Agents. In: Eisdorfer, C., Fann, W.E. (eds) Psychopharmacology and Aging. Advances in Behavioral Biology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7770-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7770-2_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7772-6
Online ISBN: 978-1-4684-7770-2
eBook Packages: Springer Book Archive